Hello everyone,
One question for you guys, if you can help me.
My company produces medical robots for surgeon interventions (class II), and for workflows use external software for planning of interventions. it consist of HW and FW and use external software for planning, for both two workflows.
Now, my team developed software for planning (with added one workflow more - third).
Question is, to submit this design change as a special 510k or traditional?
Intended use remains same (with modification that device can use either external software for planning, or new developed internal software). For nowin indications for use is stated that use external software for planning. In general device architecture was added internal software, and software development documentations is completed. Also, added one more workflow with navigation.
Is it enough, on question from FDA guidance: Is there well established method to evaluate the change? to be answer yes, because we have internal validation and verification procedures and methods, and also, software is developed according to 62304 FDA recognized standard?
Verification procedure for new version with internal software have new methods and tests applicable to new software, old version of procedure didn`t have.
Btw, for software will be used medical PC, already pre-approved (safety testing etc.)
Device is already EMC tested, and we buy EMC tested medical PC. is that enough, or we should test whole system again according to 60601-1 and 60601-1-2?
Thanks in advance.
One question for you guys, if you can help me.
My company produces medical robots for surgeon interventions (class II), and for workflows use external software for planning of interventions. it consist of HW and FW and use external software for planning, for both two workflows.
Now, my team developed software for planning (with added one workflow more - third).
Question is, to submit this design change as a special 510k or traditional?
Intended use remains same (with modification that device can use either external software for planning, or new developed internal software). For nowin indications for use is stated that use external software for planning. In general device architecture was added internal software, and software development documentations is completed. Also, added one more workflow with navigation.
Is it enough, on question from FDA guidance: Is there well established method to evaluate the change? to be answer yes, because we have internal validation and verification procedures and methods, and also, software is developed according to 62304 FDA recognized standard?
Verification procedure for new version with internal software have new methods and tests applicable to new software, old version of procedure didn`t have.
Btw, for software will be used medical PC, already pre-approved (safety testing etc.)
Device is already EMC tested, and we buy EMC tested medical PC. is that enough, or we should test whole system again according to 60601-1 and 60601-1-2?
Thanks in advance.